<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <!-- Generated by Workiva -->
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001237401</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001447028</issuerCik>
      <issuerName>Arbutus Biopharma Corporation</issuerName>
      <secFileNumber>001-34949</secFileNumber>
      <issuerAddress>
        <com:street1>701 Veterans Circle</com:street1>
        <com:city>Warminster</com:city>
        <com:stateOrCountry>PA</com:stateOrCountry>
        <com:zipCode>18974</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>267-469-0914</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>David C. Hastings</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common Shares</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Morgan Stanley Wealth Management Canada</name>
        <address>
          <com:street1>140 4th Ave. SW</com:street1>
          <com:street2>Suite 2740</com:street2>
          <com:city>Calgary</com:city>
          <com:stateOrCountry>A0</com:stateOrCountry>
          <com:zipCode>T2P3N3</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>22183</noOfUnitsSold>
      <aggregateMarketValue>72826.79</aggregateMarketValue>
      <noOfUnitsOutstanding>159724</noOfUnitsOutstanding>
      <approxSaleDate>02/04/2025</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Shares</securitiesClassTitle>
      <acquiredDate>02/03/2025</acquiredDate>
      <natureOfAcquisitionTransaction>Restricted Stock Unit Vesting</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>22183</amountOfSecuritiesAcquired>
      <paymentDate>02/03/2025</paymentDate>
      <natureOfPayment>Compensation</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <remarks>Shares to be sold to cover witholding taxes upon vesting of restricted stock units.</remarks>
    <noticeSignature>
      <noticeDate>02/04/2025</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>03/06/2023</planAdoptionDate>
      </planAdoptionDates>
      <signature>/s/ David C. Hastings</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
